Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Puma Biotechnology Inc (NASDAQ: PBYI) was $3.12 for the day, up 2.30% from the previous closing price of $3.05. In other words, the price has increased by $2.30 from its previous closing price. On the day, 0.68 million shares were traded. PBYI stock price reached its highest trading level at $3.37 during the session, while it also had its lowest trading level at $3.08.
Ratios:
Our analysis of PBYI’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.58 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.55. For the most recent quarter (mrq), Quick Ratio is recorded 1.40 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 1.21 whereas as Long-Term Debt/Eq ratio is at 0.50.
Goldman Downgraded its Neutral to Sell on October 08, 2019, whereas the target price for the stock was revised from $24 to $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when NOUGUES MAXIMO F bought 10,227 shares for $3.05 per share.
Ludwig Jeffrey Jerome bought 9,437 shares of PBYI for $28,783 on Jan 02 ’25. On Jan 02 ’25, another insider, HUNT DOUGLAS M, who serves as the Officer of the company, bought 8,633 shares for $3.05 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBYI now has a Market Capitalization of 153153616 and an Enterprise Value of 142798576. As of this moment, Puma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.57, and their Forward P/E ratio for the next fiscal year is 9.18. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63 while its Price-to-Book (P/B) ratio in mrq is 2.15. Its current Enterprise Value per Revenue stands at 0.586 whereas that against EBITDA is 3.202.
Stock Price History:
Over the past 52 weeks, PBYI has reached a high of $7.73, while it has fallen to a 52-week low of $2.22. The 50-Day Moving Average of the stock is 5.04%, while the 200-Day Moving Average is calculated to be -11.03%.
Shares Statistics:
PBYI traded an average of 437.31K shares per day over the past three months and 563070 shares per day over the past ten days. A total of 49.07M shares are outstanding, with a floating share count of 34.86M. Insiders hold about 28.99% of the company’s shares, while institutions hold 54.36% stake in the company. Shares short for PBYI as of 1734048000 were 2906650 with a Short Ratio of 6.65, compared to 1731628800 on 2983953. Therefore, it implies a Short% of Shares Outstanding of 2906650 and a Short% of Float of 6.98.
